Core Viewpoint - A class action lawsuit has been filed against Lantheus Holdings, Inc. for allegedly making false and misleading statements regarding its market position and product performance, particularly concerning Pylarify [2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 26, 2025, to August 5, 2025, with a deadline for lead plaintiff appointments set for November 10, 2025 [2]. - The complaint alleges that Lantheus overstated the market leadership of Pylarify while its competitors were gaining market share, leading to significant declines in sales throughout 2025 [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not required to participate in any recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case status at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against RxSight, Inc. for allegedly misleading shareholders regarding the company's performance and financial guidance during a specified class period [2][4]. Summary by Relevant Sections Allegations - The complaint claims that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization [2]. - It is alleged that the company overstated the demand for its products [2]. - As a result of these issues, RxSight is unlikely to meet its previously issued financial guidance for fiscal year 2025 [2]. - The positive statements made by the defendants about the company's business and prospects were materially misleading and lacked a reasonable basis [2]. Class Period and Deadlines - The class period for the lawsuit is from November 7, 2024, to July 8, 2025 [2]. - Shareholders are encouraged to register for the class action by September 22, 2025, to be eligible for potential recovery [3]. Next Steps for Shareholders - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - A class action lawsuit has been filed against iRobot Corporation for misleading investors regarding its restructuring plan and profitability after the termination of its merger agreement with Amazon [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from January 29, 2024, to March 11, 2025, with a deadline for participation set for September 5, 2025 [2]. - The complaint alleges that iRobot made false and misleading statements about the impact of its restructuring plan following the failed merger with Amazon, leading to a failure to maintain profitability as a standalone entity [2]. Group 2: Shareholder Participation - Shareholders who purchased shares of iRobot during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although this is not required to recover losses [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's status at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions, corporate governance litigation, and M&A appraisals, focusing on enhancing investor returns through advocacy [4].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit on behalf of shareholders of Alto Neuroscience, Inc. (NYSE: ANRO) who purchased shares during a specified class period, alleging that the company made materially false and misleading statements regarding its product pipeline and business prospects [1][2]. Group 1: Class Action Details - The class period for the lawsuit includes all persons and entities that purchased Alto common stock from February 2, 2024, to October 22, 2024 [1]. - Shareholders are encouraged to register for the class action by September 19, 2025, to potentially be appointed as lead plaintiff [3]. Group 2: Allegations Against Alto Neuroscience - The complaint alleges that the product pipeline, specifically ALTO-100, was less effective in treating major depressive disorder than previously claimed, leading to overstated clinical and commercial prospects [2]. - As a result of these misleading statements, Alto's overall business and financial outlook were also overstated [2]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered losses due to deceit and illegal business practices, emphasizing the importance of responsible corporate behavior [4].